HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation/Legislation (Cosmetics)

Regulation

Set Alert for Regulation (Beauty)

Latest From Beauty & Regulation

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

FDA Enforcement

House Energy & Commerce Chair Pallone Highlights Proposed Reform Bills Ahead Of Cosmetics Hearing

House Energy & Commerce Committee Chairman Frank Pallone underscores FDA’s lack of resources and insufficient “regulatory tools” in a memo to Health Subcommittee members going into a 4 December hearing on cosmetics safety issues. The committee’s last hearing on the subject was in 2012 when Pallone unveiled the first version of his Cosmetics Safety Enhancement Act.

United States Beauty

California Air Board Zeroes In On Three Personal-Care Categories For Steep VOC Reductions

Manufacturers of hair finishing sprays, no-rinse shampoos and personal fragrance products – eg, perfumes, colognes and body sprays – face significant reformulation challenges under a draft proposal from California’s Air Resources Board that contemplates fewer category impacts, but deeper VOC cuts, compared with previous considerations to help meet state-wide pollution-reduction goals.

US States Cosmetic Ingredients

FDA Warnings Target Companies US-Wide For Selling CBD Products That Violate Federal Law

CHART: The agency sent out 15 warning letters on 25 November, citing companies in 10 states for selling unapproved and misbranded CBD drug products in the guise of dietary supplements and cosmetics.

FDA Enforcement

FDA Warns 15 CBD Product Marketers For Violations, Cautions Consumers: CBD May Harm You

The agency announces that it cannot conclude cannabidiol is GRAS, potentially heading off GRAS notifications and making NDI notifications a likelier future for CBD use in the supplement sector if any “lawful pathway” is to be found. In addition to a barrage of warning letters to marketers of CBD products, the FDA issued a stark warning to consumers about potential hazards.

Dietary Supplements FDA

FDA Unfairly ‘Maligning’ Responsible CBD Product Marketers – Council For Responsible Nutrition

Dietary supplement trade groups reacted on 26 November – in CRN’s case with umbrage – to the US Food and Drug Administration’s latest barrage of cannabidiol (CBD)-themed warning letters and accompanying update to consumers regarding CBD safety.

Wellness FDA
See All

Legislation

Set Alert for Legislation (Beauty)

Latest From Beauty & Legislation

US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.

United States Beauty

House Energy & Commerce Chair Pallone Highlights Proposed Reform Bills Ahead Of Cosmetics Hearing

House Energy & Commerce Committee Chairman Frank Pallone underscores FDA’s lack of resources and insufficient “regulatory tools” in a memo to Health Subcommittee members going into a 4 December hearing on cosmetics safety issues. The committee’s last hearing on the subject was in 2012 when Pallone unveiled the first version of his Cosmetics Safety Enhancement Act.

United States Beauty

US Humane Cosmetics Act Backed By Industry And NGOs Alike; Here’s Why

The proposed bill in the US Senate could be seen as slightly friendlier to the cosmetics industry when it comes to continued use of animal testing data in limited, exempted contexts, compared with similar state laws enacted of late. But the federal bill includes stiffer penalties, addresses “cruelty free” labeling, and seeks to spur FDA acceptance of alternative test methods, a key objective for stakeholders overall.

United States Beauty

EU Reg Stands To Classify TiO2 As ‘Suspected’ Carcinogen Beginning Summer 2021

Reportedly, the Council of the European Union is considering member state objections and requests to extend the current scrutiny period beyond 4 December for a Commission delegated regulation that would classify titanium dioxide as a Category 2 carcinogen by inhalation. The move threatens to impact the marketing of sunscreens and other cosmetics in the EU that contain respirable TiO2 particles.

Europe Regulation

No Shutdown But Funding Lower Than House Bill In US FDA Budget Forecast

Former Senate Appropriations Committee staffer expects FDA's FY 2020 budget will not be finalized until early next year and that it will be close to the sum in the appropriations bill passed by the Senate.

FDA Legislation

US House Bill Would Define ‘Natural’ Cosmetic, Provide FDA Enforcement Authority

Beautycounter is among industry supporters of the Natural Cosmetic Act, introduced in the House on 5 October as the solution to greenwashing in the US personal-care sector.

United States Legislation
See All

Litigation

Set Alert for Litigation (Beauty)

Latest From Beauty & Legal Issues

Are ‘Natural’ Claims Equivalent To ‘All Natural’? Tarte’s $1.7m Settlement Offers Little Instruction

Tarte admits no wrongdoing in its settlement with nationwide purchasers of its “high performance naturals,” and it put up little fight in order to minimize costs. Insight remains limited as to whether federal courts agree with plaintiffs that general “natural” claims on cosmetic products – as opposed to “all natural” or “100% natural” assertions – mean no synthetic ingredients at all.

United States Legal Issues

Congress Members Slam FTC Over Sunday Riley Settlement, But Attorney Says Criticism Is ‘Overstated’

US lawmakers and even two FTC commissioners are critical of the agency’s proposed settlement with skin-care marketer Sunday Riley, which allegedly misled consumers for almost two years with sham product reviews posted to Sephora.com. According to Venable partner Alexandra Megaris, the company isn’t exactly getting off easy, and broader industry compliance is likely to improve as a result.

United States Legal Issues

Monat Can’t Shed Class Action Linking Its Products To Hair Loss

Eighteen plaintiffs seeking nationwide class certification may proceed with their suit alleging that Monat hair-care products, deceptively advertised as anti-aging solutions, actually cause hair loss. A US district judge on 23 October largely denied Monat’s motion to dismiss, while noting that plaintiffs may have difficulty proving that the company’s products are to blame for their injuries.

United States Legal Issues

Unilever’s Stain-Reducing Black + White Antiperspirant Is Falsely Advertised – Class Action

Compared with regular Degree MotionSense Dry Spray Antiperspirant, deceptively advertised UltraClear Black + White contains no special added technology to reduce staining; it simply has less aluminum chlorohydrate, the active ingredient that causes the very problem the product purportedly solves, says a plaintiff seeking nationwide class certification in Missouri’s Eastern District.

United States Beauty

FTC Busts Sunday Riley Skincare For Fake Sephora Reviews, But Not All Its Commissioners Are Satisfied

For close to two years, Sunday Riley management allegedly led a company-wide practice of posting glowing reviews of its products on Sephora.com without proper disclosures. The company is barred from repeating such conduct under terms reached with the FTC, but two dissenting commissioners say the settlement falls short of what’s needed to address a growing problem.

United States Advertising, Marketing & Sales

J&J Starts First Baby Powder Recall Linked To Asbestos Finding

Recall announcement doesn't mention litigation J&JU faces in multiple states alleging use of Johnson's Baby Powder causes cancer due from talc in formulation. But firm's sensitivity to consumer complaints or adverse event reports linked to brand is clear with talc-related litigation as backdrop.

OTC Drugs Cosmetic Ingredients
See All
UsernamePublicRestriction

Register